What the operation is intended to do
Surgery can establish a diagnosis, remove a localized cancer, reduce selected tumor burden or relieve obstruction, bleeding or pain. Curative intent requires an assessment of the whole disease, not simply whether one mass can be removed. Some cancers benefit from treatment before surgery; others require prompt local control.
Source [1]
Resectability and functional reserve
Imaging, pathology, cardiopulmonary fitness, nutrition and organ reserve guide planning. The surgeon should explain the likely margins, lymph-node assessment, organ preservation and possibility of conversion or a more extensive procedure. A multidisciplinary review is valuable when the sequence or extent is uncertain.
Why treatment may come before the operation
Preoperative treatment may reduce the tumor or provide information about its sensitivity. A surgeon should explain the intended operation, how response will be reassessed and what would change the plan. Conversely, not every operable cancer benefits from delay; sequence belongs to the disease-specific decision.
Source [1]
Global treatment frontiers
Surgical progress is measured by cancer control and recovery, not by incision size alone. The Chinese CLASS-01 randomized trial and long-term follow-up tested laparoscopic against open distal gastrectomy in selected locally advanced gastric cancers, helping define where a less invasive operation can preserve oncologic standards.
The comparison is also expanding beyond one type of operation. The 2025 international COLLISION trial compared thermal ablation with resection for selected small colorectal liver metastases. Such research asks when an effective local treatment can reduce procedural burden. It does not remove the need to assess margins, lesion distribution and the overall systemic-treatment strategy.
Open, laparoscopic or robotic
These are approaches to performing an operation, not separate grades of cancer care. A smaller incision can improve selected recovery outcomes, but the method must preserve oncologic quality. For some cancers and settings, an open approach remains preferable. Ask about the surgeon’s experience with the exact procedure and the reason for the proposed approach.
| Question | Why it matters |
|---|---|
| Can the cancer be removed adequately? | Margins and required lymph-node assessment come before cosmetic preference. |
| What function will remain? | Organ preservation, reconstruction and possible stomas affect daily life. |
| How experienced is the team? | Relevant procedure-specific experience matters more than the device name. |
| What is the backup approach? | Conversion to open surgery may be necessary for safe cancer removal. |
Recovery starts before the operation
Discuss nutrition, smoking cessation, activity, blood-clot prevention, pain management and expected time to restart cancer treatment. Risks include bleeding, infection, leakage or organ-specific dysfunction. The final pathology may change the postoperative plan. If traveling, agree on the minimum local recovery period and who will manage drains, wounds or complications after departure.
The final pathology may change the next step
The removed specimen can clarify tumor extent, margins, lymph nodes and response to any preoperative treatment. These findings may alter the need for postoperative therapy. Before discharge, confirm who will explain the full report and arrange the next oncology appointment; a technically successful operation is not always the end of treatment.
Plan discharge around what you can do
- Eating, walking, pain control and wound or drain care.
- Warning symptoms and a route for urgent review outside office hours.
- Blood-clot prevention, activity limits and timing of longer travel.
- How complications would affect starting or resuming systemic treatment.
Source [1]
Estimated total treatment cost
The ranges below cover one cancer operation and associated perioperative medical care. Costs depend on the procedure, extent of resection, surgical approach and recovery needs.
| Operation | Estimated total treatment cost |
|---|---|
| Thyroid cancer surgery | US$10,000–21,000 |
| Breast cancer surgery, without reconstruction | US$12,000–26,000 |
| Thoracoscopic lung segmentectomy or lobectomy | US$18,000–38,000 |
| Colorectal cancer resection | US$21,000–43,000 |
| Partial or total gastrectomy for cancer | US$25,000–52,000 |
| Liver cancer resection | US$26,000–55,000 |
| Pancreaticoduodenectomy (Whipple procedure) | US$37,000–75,000 |
| Robot-assisted radical prostatectomy | US$23,000–45,000 |
What’s included
The total includes surgical and anesthesia assessment, necessary preoperative tests and imaging, surgeon and anesthesia fees, the operating room, routine instruments and consumables, pathology, necessary hospitalization and nursing, routine medicines, basic nutritional and rehabilitation support, and early follow-up. The robot-assisted prostatectomy range includes the robotic equipment and dedicated consumables. Travel and accommodation are not included.
Your treatment plan
The extent of lymph-node surgery, reconstruction, combined organ resection and any additional care can change the overall cost. Breast reconstruction, transplantation, later stoma reversal, separately arranged anticancer medicines or radiotherapy, and long-term rehabilitation are assessed separately. Contact us for a personalized estimate based on your proposed operation and care needs.
Evidence & sources
Prepared by Chirona’s content team from the sources below. This guide supports a discussion with your treating team; it does not determine an individual treatment plan.